Normal forms, stability and splitting of invariant manifolds I. Gevrey Hamiltonians

In this paper, we give a new construction of resonant normal forms with a small remainder for near-integrable Hamiltonians at a quasi-periodic frequency. The construction is based on the special case of a periodic frequency, a Diophantine result concerning the approximation of a vector by independent periodic vectors and a technique of composition of periodic averaging. It enables us to deal with non-analytic Hamiltonians, and in this first part we will focus on Gevrey Hamiltonians and derive normal forms with an exponentially small remainder. This extends a result which was known for analytic Hamiltonians, and only in the periodic case for Gevrey Hamiltonians. As applications, we obtain an exponentially large upper bound on the stability time for the evolution of the action variables and an exponentially small upper bound on the splitting of invariant manifolds for hyperbolic tori, generalizing corresponding results for analytic Hamiltonians.

Normal forms, stability and splitting of invariant manifolds II. Finitely differentiable Hamiltonians

This paper is a sequel to ``Normal forms, stability and splitting of invariant manifolds I. Gevrey Hamiltonians", in which we gave a new construction of resonant normal forms with an exponentially small remainder for near-integrable Gevrey Hamiltonians at a quasi-periodic frequency, using a method of periodic approximations. In this second part we focus on finitely differentiable Hamiltonians, and we derive normal forms with a polynomially small remainder. As applications, we obtain a polynomially large upper bound on the stability time for the evolution of the action variables and a polynomially small upper bound on the splitting of invariant manifolds for hyperbolic tori.

Groupe thérapeutique de gestion des émotions: un territoire d'acquisition des compétences chez les patientsavec trouble de la personnalité borderline

Dans cet article, nous présenterons le modèle biopsychosocial du trouble de la personnalité borderline et le mettrons en lien avec les critères développés dans les manuels diagnostiques (DSM-IV-TR, CIM-70). Seront ensuite explicité les principaux cadres de prise en charge de la thérapie comportementale-dialectique (TCD), tels que conçus par Marsha M. Linehan. Le modèle des dimensions de l'ouverture émotionnelle permettra d'enrichir la conceptualisation des émotions de la TCD. Nous insisterons particulièrement sur le groupe thérapeutique de Gestion des Émotions, inspiré des principes constitutifs de la TCD. Les pruniers résultats d'une étude pilote et la présentation d'une étude randomisée contrôlée seront discutés, en tenant compte des exigences cliniques et des considérations méthodologiques de l'évaluation des psychothérapies.

Differential control of Notch1 gene transcription by Klf4 and Sp3 transcription factors in normal versus cancer-derived keratinocytes.

In specific cell types like keratinocytes, Notch signaling plays an important pro-differentiation and tumor suppressing function, with down-modulation of the Notch1 gene being associated with cancer development. Besides being controlled by p53, little else is known on regulation of Notch1 gene expression in this context. We report here that transcription of this gene is driven by a TATA-less "sharp peak" promoter and that the minimal functional region of this promoter, which extends from the -342 bp position to the initiation codon, is differentially active in normal versus cancer cells. This GC rich region lacks p53 binding sites, but binds Klf4 and Sp3. This finding is likely to be of biological significance, as Klf4 and, to a lesser extent, Sp3 are up-regulated in a number of cancer cells where Notch1 expression is down-modulated, and Klf4 over-expression in normal cells is sufficient to down-modulate Notch1 gene transcription. The combined knock-down of Klf4 and Sp3 was necessary for the reverse effect of increasing Notch1 transcription, consistent with the two factors exerting an overlapping repressor function through their binding to the Notch1 promoter.

Genes for normal sleep and sleep disorders.

Sleep and wakefulness are complex behaviors that are influenced by many genetic and environmental factors, which are beginning to be discovered. The contribution of genetic components to sleep disorders is also increasingly recognized as important. Point mutations in the prion protein, period 2, and the prepro-hypocretin/orexin gene have been found as the cause of a few sleep disorders but the possibility that other gene defects may contribute to the pathophysiology of major sleep disorders is worth in-depth investigations. However, single gene disorders are rare and most common disorders are complex in terms of their genetic susceptibility, environmental effects, gene-gene, and gene-environment interactions. We review here the current progress in the genetics of normal and pathological sleep.

Hypoglycémie et traitement du diabète de type 2. Le retour à une normoglycémie n'est pas nécessairement la meilleure stratégie thérapeutique [Hypoglycemia and diabetes treatment: the return to normal glucose level is not always the best therapeutic strategy].

Recent clinical trials with type 2 diabetic patients and the quest of normal glyceamic values, have revealed difficulties and limitations. These too normal glyceamic targets corresponding to the physiological standards are associated with very high rate of hypoglycemia and an increase of mortality. A too simplistic view of treatment: "the lowest, the better is in the diabetes" is no longer defensible. The knowledge from complex systems behavior invites us to search targets adapted to a new state of equilibrium due to loss of self-regulation. These targets should not aim the physiological standards but to be adapted to patient's situation. Shared decision-making and consensus are the two pillars of this new strategy supported by the new ADA-EASD guidelines.

Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.

A synthetic human atrial natriuretic peptide of 26 aminoacids [human (3-28)ANP or hANP] was infused into normal male volunteers. Six subjects were infused for 4 h at 1-wk intervals with either hANP at the rate of 0.5 or 1.0 microgram/min or its vehicle in a single-blind randomized order. Human (3-28)ANP at the dose of 0.5 microgram/min raised immunoreactive plasma ANP levels from 104 +/- 17 to 221 +/- 24 pg/ml (mean +/- SEM), but it induced no significant change in blood pressure, heart rate, effective renal plasma flow, glomerular filtration rate, or renal electrolyte excretion. At the rate of 1.0 microgram/min, human (3-28)ANP increased immunoreactive plasma ANP levels from 89 +/- 12 to 454 +/- 30 pg/ml. It reduced effective renal plasma flow from 523 +/- 40 to 453 +/- 38 ml/min (P less than 0.05 vs. vehicle), but left glomerular filtration rate unchanged. Natriuresis rose from 207 +/- 52 to 501 +/- 69 mumol/min (P less than 0.05 vs. vehicle) and urinary magnesium excretion from 3.6 +/- 0.5 to 5.6 +/- 0.5 mumol/min (P less than 0.01 vs. vehicle). The excretion rate of the other electrolytes, blood pressure, and heart rate were not significantly modified. At both doses, human (3-28)ANP tended to suppress the activity of the renin-angiotensin-aldosterone system. In 3 additional volunteers, the skin blood flow response to human (3-28)ANP, infused for 4 h at the rate of 1.0 microgram/min, was studied by means of a laser-doppler flowmeter. The skin blood flow rose during the first 2 h of peptide administration, then fell progressively to values below baseline. After the infusion was discontinued, it remained depressed for more than 2 h. Thus, in normal volunteers, human (3-28)ANP at the dose of 1.0 microgram/min produced results similar to those obtained previously with rat (3-28)ANP. It enhanced natriuresis without changing the glomerular filtration rate while effective renal plasma flow fell. It also induced a transient vasodilation of the skin vascular bed.

L'expression des E-cadherines et des calretinines dans les tumeurs sérieuses borderline de l'ovaire : un facteur pronostique ?

Résumé: Les tumeurs séreuses dites "borderline" de l'ovaire sont rares. Si leur pronostic est bon chez la très grande majorité des patientes (90-96%), leur traitement reste controversé, surtout chez la femme jeune. Ces tumeurs peuvent récidiver surtout sous la forme d'implants péritonéaux résultant de la colonisation du péritoine par des cellules tumorales qui, ayant perdu leur capacité d'adhésion, se détacherait de la tumeur primaire et essaimeraient dans l'espace péritonéal. C'est la présence ou non de ces implants qui détermine l'évolution à moyen ou à long terme. Le but de cette étude est d'évaluer la valeur pronostique de l'expression, par les cellules tumorales, d'une molécule d'adhésion, la E-cadhérine et des calrétinines, protéines susceptible de stimuler le cycle cellulaire et donc d'être un marqueur d'agressivité. En d'autre termes, il s'agirait de pouvoir distinguer entre les tumeurs à bon et celles à mauvais pronostic, et cela afin d'optimaliser le traitement. A cet effet, nous avons analysé une série de 57 patientes ayant présenté ce type de tumeurs. Lors du diagnostic 12 des 23 patientes dont la tumeur avait une composante exophytique présentaient des implants péritonéaux, ceux-ci ayant un caractère invasif chez 2 patientes. Quatre patientes ont présenté une récidive, toutes sauf 1 provenaient de tumeur exophytique, et une en est décédée. Aucun implant fut retrouvé chez les 34 femmes porteuses d'une tumeur exclusivement endophytique. Sur 57 tumeurs, 20 ne présentaient pas de marquage par les E-cadhérines, 4 implants non-invasifs étaient marqués sur 10, et les implants invasifs étaient tous les 2 marqués. Ceci pourrait s'expliquer par une surexpression d'une protéine non fonctionnelle. L'immunomarquage par les calrétinines était présent chez 40 tumeurs, chez 5 implants non-invasifs sur 10, et fortement chez les 2 implants invasifs. Cette protéine pourrait peut-être permettre de distinguer les implants invasifs au pronostic plus sombre

Práticas assistenciais em reanimação do recém-nascido no contexto de um centro de parto normal

Aproximadamente 10 a 15% dos recém-nascidos (RNs) apresentam dificuldades de adaptação ao nascimento, o que requer habilidade e prontidão dos profis-sionais para intervir nessas situações. Este estudo observacional, transversal objetivou descrever as práticas assistenciais empregadas em reanimação neo-natal em um Centro de Parto Normal de um hospital público de São Paulo. Observou-se 100 atendimentos prestados pela equipe profissional e os dados foram registrados em um instrumento checklist. A presença de líquido meconial foi constatada em 24 (24,0%) partos e a aspiração das vias respiratórias foi realizada em 47 (47,0%) RNs. Desse total, 3 (6,4%) tiveram a traquéia aspirada e 26 (26,0%) RNs receberam oxigenação, sendo que 5 (19,2%) com máscara aberta e pressão positiva. Massagem cardíaca foi realizada em 1 (1,0%) RN. Após a reanimação neonatal inicial, 6 (6,0%)RNs foram transferidos à UTI neonatal devido desconforto respiratório.

Centro de parto normal e a assistência obstétrica centrada nas necessidades da parturiente

Levando em conta os vários estudos e reflexões a respeito do novo modelo de assistência ao parto e nascimento (assistência humanizada), e trabalhando como enfermeira obstétrica em um Centro de Parto Normal, surgiu o questionamento a respeito desse conceito, devido às diversas conotações dadas a esse termo. Este artigo foi produzido com a finalidade de divulgar nossa proposta de substituição da expressão "assistência humanizada ao parto", por "assistência obstétrica centrada nas necessidades da parturiente", e de discorrer como essa assistência é prestada no Centro de Parto Normal do Hospital Geral de Itapecerica da Serra (SP), que segue um protocolo de condutas obstétricas e normas preconizadas pelo Ministério da Saúde.

Fructose-rich diet-induced abdominal adipose tissue endocrine dysfunction in normal male rats.

We have currently studied the changes induced by administration of a fructose-rich diet (FRD) to normal rats in the mass and the endocrine function of abdominal (omental) adipose tissue (AAT). Rats were fed ad libitum a standard commercial chow and tap water, either alone (control diet, CD) or containing fructose (10%, w/vol) (FRD). Three weeks after treatment, circulating metabolic markers and leptin release from adipocytes of AAT were measured. Plasma free fatty acids (FFAs), leptin, adiponectin, and plasminogen activator inhibitor-1 (PAI-1) levels were significantly higher in FRD than in CD rats. AAT mass was greater in FRD than in CD rats and their adipocytes were larger, they secreted more leptin and showed impaired insulin sensitivity. While leptin mRNA expression increased in AAT from FRD rats, gene expression of insulin receptor substrate, IRS1 and IRS2 was significantly reduced. Our study demonstrates that administration of a FRD significantly affects insulin sensitivity and several AAT endocrine/metabolic functions. These alterations could be part of a network of interacting abnormalities triggered by FRD-induced oxidative stress at the AAT level. In view of the impaired glucose tolerance observed in FRD rats, these alterations could play a key role in both the development of metabolic syndrome (MS) and beta-cell failure.

Fatores relacionados ao trauma perineal no parto normal em nulíparas

Inúmeros estudos têm sido realizados com a finalidade de contribuir para a prevenção do trauma perineal no parto normal. O objetivo do presente estudo foi relacionar a altura do períneo, duração do período expulsivo, variedade de posição no desprendimento cefálico, tipo de puxo, presença de circular de cordão, peso do recém-nascido e ardor na vulva ao urinar com a ocorrência de lacerações perineais. A pesquisa foi realizada em 2003, no Centro de Parto Normal do Amparo Maternal, com uma amostra de 67 parturientes sem partos vaginais anteriores. Os resultados mostraram que não houve diferença estatisticamente significante em relação às variáveis analisadas.

Traço e estado de ansiedade de nutrizes com indicadores de hipogalactia e nutrizes com galactia normal

Este estudo objetivou identificar e comparar o traço e estado de ansiedade, no 10º dia pós-parto e estado de ansiedade no 30º dia puerperal, das nutrizes primíparas e multíparas que apresentaram indicadores de hipogalactia e nutrizes com galactia normal; verificar possíveis relações entre o estado de ansiedade das nutrizes nesses dois momentos com a presença dos indicadores de hipogalactia. É um estudo exploratório/descritivo, cujos dados foram obtidos com 168 nutrizes e seus filhos, por meio de entrevistas realizadas em consulta de enfermagem nos 10º e 30º dias pós-parto. Os resultados obtidos mostraram que as primíparas e multíparas hipogalactas e as primíparas com galactia normal apresentaram traço de ansiedade mais elevado do que os estados de ansiedade por ocasião do 10º e 30º dia pós-parto. Houve remissão dos sinais maternos de ansiedade, com o passar do tempo, que pode ter sido decorrente da correção da técnica da amamentação e apoio às nutrizes.

Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.

Two new forms of non-specific crossreacting antigens (NCAs) were identified in the Nonidet P40 (NP-40) extracts of normal granulocytes by precipitation with the monoclonal antibody (MAb) 192 directed against carcinoembryonic antigen (CEA) and already known to crossreact with the perchloric acid soluble NCA-55. The NP-40 soluble NCAs recognized by MAb 192 have apparent mol. wts of 90,000 and 160,000 in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Both NCAs appear to consist of a single monomeric polypeptide chain, since they have the same electrophoretic mobility in SDS-PAGE under reduced and non-reduced conditions. When granulocytes were extracted with perchloric acid instead of NP-40, only the 55,000 mol. wt antigen, corresponding to the previously described NCA-55, was precipitated by MAb 192. Furthermore, it was shown that NCA-55 is not a degradation product of NCA-90 or NCA-160 due to the perchloric acid treatment because exposure to perchloric acid of NCA preparations purified from NP-40 extracts did not change their apparent mol. wts in SDS-PAGE. It was also shown that NCA-160 is not a granulocytic form of CEA because it was not precipitated by the MAb 35 reacting exclusively with CEA. Immunocytochemical studies of granulocytes and macrophages showed that MAb 192 stained both types of cells whereas MAb 47 stained only the granulocytes and MAb 35 none of these cells. In granulocytes both MAbs reacted with antigens associated with granules and also present at the periphery of the nucleus as well as in the Golgi apparatus. The NCA-90 identified by MAb 192 was found by sequential immunodepletion to be antigenically distinct from the NCA-95 precipitated by MAb 47. The epitope recognized by MAb 192 on CEA and NCA molecules appears to be on the peptidic moiety because the antigens deglycosylated by the enzyme Endo F were still precipitated by this MAb. Taken together, the results indicate that MAb 192 identifies two novel forms of NCA (NCA-90 and NCA-160) in NP-40 extracts of granulocytes, which are distinct from CEA and the previously described NCA-55 and NCA-95 identified by MAbs 192 and 47, respectively, in perchloric acid extracts of granulocytes.